[{"Assets_0_Q1_USD":6214912000.0,"EarningsPerShareBasic_1_Q1_USD":22.05,"EarningsPerShareDiluted_1_Q1_USD":21.77,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":40346000.0,"NetIncomeLossConverted_1_Q1_USD":656774000.0,"RevenuesConverted_1_Q1_USD":551519000.0,"StockholdersEquity_0_Q1_USD":4488091000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":30171000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29787000.0,"Ticker":"BIO","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20180510"}]